Care Collabrative Home Health is categorized under Home Health Care Services in Chicago, IL and active since 2004.
Care Collabrative Home Health was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 6216100 by the NAICS.
If you are seeking more information, feel free to contact Keith L Wolski at the company’s single location by writing to 217 East 31st St # 1, Chicago, Illinois IL 60616 or by phoning (312) 949-1010. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Care Collabrative Home Health |
| Contact Person: | Keith L Wolski |
| Address: | 217 East 31st St # 1, Chicago, Illinois 60616 |
| Phone Number: | (312) 949-1010 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 6216100 |
| Share This Business: |
Care Collabrative Home Health was started in 2004 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Keith L Wolski for inquiries that concern Care Collabrative Home Health by calling the company number (312) 949-1010, as your correspondence is most welcome. Additionally, the physical location of the single location of Care Collabrative Home Health can be found at the coordinates 41.838382,-87.620441 as well as the street address 217 East 31st St # 1 in Chicago, Illinois 60616.
For its online presence, you may visit Care Collabrative Home Health’s website at and engage with its social media outlets through on Twitter and on Facebook.